Shots: In 2024, EMA approved around 53 drugs in various therapy areas, ranging from cardiology, oncology, hematology, neurology, and dermatology to infectious diseases, vaccines, diagnostic agents, pneumology, nephrology, hepatology, ophthalmology, and endocrinology PharmaShots, in an illuminating report, brings a condensed analysis of the approved drugs with the most explored areas being Oncology, Hematology, Neurology, &…
20 Emerging Animal Health Companies of IndiaShots:Owing to the agrarian origin and rise in pet ownership trends, the animal healthcare sector in India has witnessed a significant boomIn 2023, the animal healthcare market size was valued at $1.9B and is anticipated to grow to $4.3B by 2030, registering a CAGR of 12.3%…
Shots:CDMOs are at the forefront of pharmaceutical manufacturing, shaping the industry's growth by meeting the increasing global demand for pharmaceutical productsIn 2023, the global CDMO market was valued at $224.86B, with projections to reach $465.14B by 2032, demonstrating a CAGR of 8.5%PharmaShots presents a comprehensive report on the 20 Contract Development and…
Shots:Known for delivering the same therapeutic benefits as its brand-name counterpart, it won't be an exaggeration to refer to generic drugs as modern-day advocates for health equityIn 2022, the global market size of generic drugs was valued at $411.99B and is envisioned to reach $613.34B by 2030 with a CAGR of 5.10%. Sandoz…

